Dowling & Yahnke’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $134K | Hold |
7,523
| – | – | 0.01% | 360 |
|
|
2022
Q2 | $167K | Hold |
7,523
| – | – | 0.01% | 358 |
|
|
2022
Q1 | $209K | Hold |
7,523
| – | – | 0.01% | 355 |
|
|
2021
Q4 | $342K | Hold |
7,523
| – | – | 0.02% | 301 |
|
|
2021
Q3 | $627K | Hold |
7,523
| – | – | 0.03% | 249 |
|
|
2021
Q2 | $715K | Hold |
7,523
| – | – | 0.04% | 232 |
|
|
2021
Q1 | $1.25M | Hold |
7,523
| – | – | 0.09% | 187 |
|
|
2020
Q4 | $737K | Hold |
7,523
| – | – | 0.05% | 219 |
|
|
2020
Q3 | $256K | Hold |
7,523
| – | – | 0.02% | 280 |
|
|
2020
Q2 | $427K | Hold |
7,523
| – | – | 0.04% | 240 |
|
|
2020
Q1 | $441K | Buy |
7,523
+1,258
| +20% | +$73.7K | 0.04% | 223 |
|
|
2019
Q4 | $495K | Sell |
6,265
-342
| -5% | -$27K | 0.04% | 237 |
|
|
2019
Q3 | $661K | Buy |
+6,607
| New | +$661K | 0.05% | 215 |
|